Literature DB >> 12030602

Psychological and emotional development, intellectual capabilities, and body image in short normal children.

E Molinari1, A Sartori, A Ceccarelli, S Marchi.   

Abstract

It is well established that children with short stature frequently have problems in cognitive development, personality, self-esteem and social relations. This is partly due to the fact that many parents view them as more vulnerable than other children of normal stature and do not allow them to face the normal experiences that correspond to their actual age. The aim of the present study was to assess, through the administration of appropriate psychological tools, a series of psychological and cognitive characteristics [i.e. anxiety, depression, good adjustment, social functioning, feeling of guilt, interpersonal relationship, intelligence quotient (IQ)], as well as variables linked to development of body image, in a group of children suffering from normal growth variants [familial short stature (FSS), no. 10, 4 males/6 females; with constitutional growth delay (CGD), no. 4,4 males; height standard deviation score (HSDS) ranging between -2.4 and -1.9] and in a control group children of normal stature (HSDS between -0.1 and +0.1). Children with short stature significantly differed from normal statured controls as far as Colored Progressive Matrices (CPMs, centiles), IQ (IQ, obtained using the Goodenough test), "Good Adjustment" (Draw-a-Person index, DAP), "Feelings of Guilt" (DAP index), "Height" (as emerges from drawings of the body) are concerned. Significant relationships were found between the height of the subjects (in centiles) and cognitive skills, measured both using CPMs (r=0.408; p=0.017) and Draw-a-Man (DAM) (r=0.359; p=0.037) and between height and feelings of guilt (r=0.325; p=0.027), measured using DAP. CPM scores correlated positively with the "Good Adjustment" index of DAP (r=0.354; p=0.05) and negatively with Children's Depression Inventory (CDI) (r=-0.609; p=0.01), "School Anxiety" index (r=-0.427; p=0.05) and "Total Anxiety" index (r=-0.436; p=0.05) of the Anxiety Scale Questionnaire for the Age of Development, and with 2 indices of DAP, namely, "Feelings of Guilt" (r=-0.461; p=0.01) and "Interpersonal Relationships (Difficulty in Establishing)" (r=-0.455; p=0.01). A significant positive correlation was found between the height of the subject and both the measurement of the "Body of Drawing 3" (r=0.450, p=0.01) and the measurement of the "Body of Drawing 4" (r=0.461, p=0.01), as well as the with the "Total Height of Drawing 4" (r=0.464, p=0.01). Higher indices for anxiety, depression, feelings of guilt and difficulty in establishing interpersonal relationships and lower indices for good adjustment were found in children with CGD as compared to subjects with FSS or normal statured children. Although further additional studies on larger samples are needed to confirm these preliminary observations, the present study underlines the importance of psychological support also during the growth and development in short normal children.

Entities:  

Mesh:

Year:  2002        PMID: 12030602     DOI: 10.1007/bf03344012

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

1.  Psychosocial outcome of children evaluated for short stature.

Authors:  G D Zimet; R Owens; W Dahms; M Cutler; M Litvene; L Cuttler
Journal:  Arch Pediatr Adolesc Med       Date:  1997-10

Review 2.  Growth, growth hormone and cognitive functions.

Authors:  A Sartorio; A Conti; E Molinari; G Riva; F Morabito; G Faglia
Journal:  Horm Res       Date:  1996

3.  Final height in non-growth hormone deficient children treated with growth hormone. The Italian Multicentre Study Group.

Authors:  S Bernasconi; M E Street; C Volta; G Mazzardo
Journal:  Clin Endocrinol (Oxf)       Date:  1997-09       Impact factor: 3.478

4.  Short stature and psychosocial assessment.

Authors:  L D Voss; I Wiklund
Journal:  Acta Paediatr Suppl       Date:  1995-09

Review 5.  Growth hormone deficiency in children has psychological and educational co-morbidity.

Authors:  B Stabler; P T Siegel; R R Clopper
Journal:  Clin Pediatr (Phila)       Date:  1991-03       Impact factor: 1.168

6.  Psychological adjustment of children evaluated for short stature: a preliminary report.

Authors:  G D Zimet; M Cutler; M Litvene; W Dahms; R Owens; L Cuttler
Journal:  J Dev Behav Pediatr       Date:  1995-08       Impact factor: 2.225

7.  Short stature--the role of intelligence in psychosocial adjustment.

Authors:  J Gilmour; D Skuse
Journal:  Arch Dis Child       Date:  1996-07       Impact factor: 3.791

8.  Academic achievement and psychological adjustment in short children. The National Cooperative Growth Study.

Authors:  B Stabler; R R Clopper; P T Siegel; C Stoppani; P G Compton; L E Underwood
Journal:  J Dev Behav Pediatr       Date:  1994-02       Impact factor: 2.225

9.  Short stature: a psychosocial burden requiring growth hormone therapy?

Authors:  D E Sandberg; A E Brook; S P Campos
Journal:  Pediatrics       Date:  1994-12       Impact factor: 7.124

10.  Psychosocial assessment of children with short stature: a preliminary report.

Authors:  D Skuse; J Gilmour; C S Tian; P Hindmarsh
Journal:  Acta Paediatr Suppl       Date:  1994-12
View more
  3 in total

1.  Health-related quality of life and cognitive functioning in pediatric short stature: comparison of growth-hormone-naïve, growth-hormone-treated, and healthy samples.

Authors:  Matthew D Stephen; James W Varni; Christine A Limbers; Michael Yafi; Rubina A Heptulla; Venkat S Renukuntla; Cynthia S Bell; Patrick G Brosnan
Journal:  Eur J Pediatr       Date:  2010-10-01       Impact factor: 3.183

Review 2.  Early recognition of growth abnormalities permitting early intervention.

Authors:  Morey Haymond; Anne-Marie Kappelgaard; Paul Czernichow; Beverly M K Biller; Koji Takano; Wieland Kiess
Journal:  Acta Paediatr       Date:  2013-05-13       Impact factor: 2.299

Review 3.  The effect of adolescent inhalant abuse on energy balance and growth.

Authors:  Rose Crossin; Ashleigh Qama; Zane B Andrews; Andrew J Lawrence; Jhodie R Duncan
Journal:  Pharmacol Res Perspect       Date:  2019-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.